Future studies should investigate (1) the AHR ligands present in PM and how they alter T cell response and (2) the specific AHR pathway components required for responses in order to generate therapies to decrease autoimmune disease and hopefully prevent disease onset secondary to PM exposure. Here, AHR is linked to autoimmune disease.